Positive Bioscience

Mumbai, India Founded: 2012 • Age: 14 yrs
DNA tests for cancer treatment and hereditary screening are provided.
Annual revenue - Latest available
Total funding $465,663 1 rounds
Employees - Tracked headcount
Investors 12 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Positive Bioscience

Positive Bioscience is a company based in Mumbai (India) founded in 2012. Positive Bioscience has raised $465.66 thousand across 1 funding round from investors including Savitha Palanki, Suma Radheshyam and Manjiri Somashekhar. Positive Bioscience operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.

  • Headquarter Mumbai, India
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $465.66 K (USD)

    in 1 rounds

  • Latest Funding Round
    $465.66 K (USD), Angel Round

    Nov 11, 2018

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Positive Bioscience

Positive Bioscience has successfully raised a total of $465.66K through 1 strategic funding round. The most recent funding activity was a Angel Round of $465.66 thousand completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Angel Round — $465,663
  • First Round

    (11 Nov 2018)

  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2018 Amount Angel Round - Positive Bioscience Valuation Savitha Palanki , Suma Radheshyam

Investors in Positive Bioscience

Positive Bioscience has secured backing from 12 investors, including angel and institutional investors. Prominent investors backing the company include Savitha Palanki, Suma Radheshyam and Manjiri Somashekhar.

All
Institutional
Angel
Investor Description Founded Year Domain Location
-
Founded Year Domain Location

Savitha Palanki

-
Founded Year Domain Location

Suma Radheshyam

-
Founded Year Domain Location

Investments & Acquisitions by Positive Bioscience

Investments

Financial Statements - Positive Bioscience

Positive Bioscience Comparisons

+
Add Comparison
Available on Premium

Competitors of Positive Bioscience

Positive Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
domain founded_year HQ Location
Genomic sequencing and diagnosis software is provided for healthcare.

Latest news on Positive Bioscience

Frequently Asked Questions about Positive Bioscience

Positive Bioscience was founded in 2012 and raised its 1st funding round 6 years after it was founded.

Positive Bioscience is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Positive Bioscience is a funded company, having raised a total of $465.66K across 1 funding round to date. The company's 1st funding round was a Angel Round of $465.66K, raised on Nov 11, 2018.

Positive Bioscience was established in 2012 in Mumbai, India, within the biotechnology sector focused on genomics. Services encompassing DNA testing for cancer treatment personalization and hereditary cancer risk screening are delivered. Operations center on diagnostic solutions to support clinical decisions in oncology. The company addresses healthcare needs in the Indian market through laboratory-based genetic analysis.

Positive Bioscience's top competitors include Guardant Health, Foundation Medicine and Personalis.

Positive Bioscience has 12 investors. Key investors include Savitha Palanki, Suma Radheshyam, Manjiri Somashekhar, Sabhyata Gupta, and Arwa Eranpurwala.

The valuation of Positive Bioscience is $2.86M as of Nov 2018.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available